Ross S., Grant A., Counsell C., Gillespie W., Russel I., Prescott R.Barriers to participation in randomised controlled trials: a systematic review . J Clinical Epidemiol.1999;52:1143-1156.
2.
Larzeler RE, Kuhn BR, Johnson B.The intervention selection bias: an unrecognized confound in intervention research. Psychol Bull.2004;130:289-303.
3.
Moher D., Schulz KF, Altman DGThe CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001;357:1191-1194.
4.
Britton A., McKee M., Black N., McPherson K., Sanderson C., Bain C.Threats of applicability of randomised trials: exclusions and selective participation . J Health Serv Res Policy.1999;4:112-121.
5.
Rothwell PMExternal validity of randomised controlled trials: “to whom do the results of this trial apply.” Lancet. 2005;365:82-93.
6.
Hunninghake DB , Darby CA, Probstfield JLRecruitment experience in clinical trials: literature summary and annotated bibliography. Control Clin Trials.1987;8:6s-30s.
7.
Glasgow RE, Toobert DJ, Hampson SEParticipation in outpatient diabetes education program: how many patients take part and how representative are they?Diabetes Educ. 1991;17:376-380.
8.
Froehlicher ES , Lorig K.Editorial: who cares about recruitment anyway ? Patient Educ Couns.2002;48:97.
9.
Ellis PMAttitudes towards and participation in randomised clinical trials in oncology: a review of the literature. Ann Oncol.2000 ; 11:939-945.
10.
Torgerson DJ, Klaber-Moffet J., Russel ITPatient preferences in randomised trials: threat or opportunity, J Health Serv Res Policy.1996;1:194-197.
11.
Featherstone K., Donovan JLRandom allocation or allocation at random? Patients perspectives on participation in a randomised controlled trial. Br Med J.1998;317:1177-1180.
12.
Toobert DJ, Strycker LA, Glasgow RE, Bagdade JDIf you build it will they come? Reach and adoption associated with a comprehensive lifestyle management program for women with type 2 diabetes. Patient Educ Couns. 2002;48:99-105.
13.
Lauritzen T. , Griffin S., Borch-Johnsen K., Wareham Njm, Wolffenbuttel BH, Rutten G.The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening . Int J Obes Relat Metab Disord.2000; 24:S6-S11.
14.
Adriaanse MC , Snoek FJ, Dekker JM, van der Ploeg HM, Heine RJScreening for type 2 diabetes: an exploration of subject's perceptions regarding diagnosis and procedure. Diabetes Med.2002;19:1-6.
15.
Thoolen BJ, de Ridder D., Bensing J., Gorter K., Rutten G.Beyond good intentions: the development and evaluation of a proactive self-management course for patients recently diagnosed with type 2 diabetes. Health Educ Res. Epub ahead of print February7, 2007. DOI: 10.1093/her/cyl160.
16.
DasEHHJ. How Fear Appeals Work: Motivational Bias in the Processing of Fear-ArousingHealth Communications. Utrecht, the Netherlands: Utrecht University; 2001.
17.
Skinner TC, Howells L., Greene S., Edgar K., McEvilly A., Johansson A.Development, reliability and validity of the diabetes illness representations questionnaire. Diabetes Med.2003;20:283-289.
18.
Toobert DJ, Hampson SE, Glasgow REThe summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23:943-950.
19.
Lorig K., Stewart A., Ritter P., Gonzales V., Laurent D., Lynch J.Outcome Measures for Health Education and Other Health Care Interventions . Thousand Oaks, Calif: Sage; 1996.
20.
Kuijer RG, de Ridder DTD.Discrepancy in illness-related goals and quality of life in chronically ill patients: the role of self-efficacy. Psychol Health. 2003;18:313-330.
21.
Adriaanse MC , Snoek FJThe psychological impact of screening for type 2 diabetes. Diabetes Metab Res Rev. 2006 ;22:20-25.
22.
Thoolen BJ, de Ridder D., Bensing J., Gorter K., Rutten G.Psychological outcomes of screen-detected patients with type 2 diabetes: the influence of time since diagnosis and treatment intensity. Diabetes Care.2006;29:2257-2262.
23.
Banks J., Marmot M., Oldfield Z., Smith JPDisease and disadvantage in the United States and in England. JAMA.2006;295:2037-2045.
24.
Uitewaal P. , Bruijnzeels P., de Hoop T., Hoes A., Thomas S.Feasibility of diabetes peer education for Turkish type 2 diabetes patients in Dutch general practice. Patient Educ Couns.2004; 53:359-363.
25.
Poos Mjjc, Eysink Ped, Gommer AM, van der Wilk EA, Harbers MMDiabetes mellitus. Omvang van het probleem. In: Volksgezondheid Toekomst Verkenning, Nationaal Kompas Volksgezondheid.Bilthoven, RIVM, 2004. Available at: http://www.nationaalkompas.nl.
